Insilico Medicine
AI-driven drug discovery
Enterprise biotech solution
Accelerates R&D
Global partnerships
ISO 27001 certified
Accelerate drug discovery and development with generative AI and automation.
Last updated: Apr 15, 2026
ENTERPRISE
insilico.com
Quick Answer
Insilico Medicine is an AI-driven biotech company that uses generative AI to accelerate drug discovery and development. Its Pharma.AI platform identifies novel targets, generates new molecules and biologics, and predicts clinical trial outcomes. Best for large pharmaceutical companies and research institutions seeking to transform their R&D processes. It operates on an enterprise model with custom solutions.
About Insilico Medicine
Insilico Medicine is a leading end-to-end generative AI-driven biotech company transforming drug discovery and development. It leverages its proprietary Pharma.AI platform across biology, chemistry, and clinical development to rapidly advance novel drug candidates. The platform significantly reduces the time and cost to bring life-saving medications to patients, partnering with top pharmaceutical companies globally.
What Makes It Unique
Insilico Medicine offers an end-to-end generative AI-driven platform, Pharma.AI, that covers target identification (PandaOmics), novel molecule generation (Chemistry42), biologics design (Generative Biologics), and clinical trial prediction (inClinico), creating a fully integrated drug discovery pipeline.
Use Cases & Target Users
Best For
Accelerating drug discovery for pharmaceutical companies
Identifying novel therapeutic targets for disease treatment
Generating new small molecules and biologics with desired properties
Optimizing clinical trial design and predicting outcomes
Enhancing scientific research with AI-driven insights
Company Size
ENTERPRISE
Fit Score
Complexity
ADVANCED
Target Team Size
LARGE_TEAM
Target Skill Level
EXPERT
Key Features
AI-driven target discovery and disease modeling (PandaOmics)
Generative chemistry for novel small molecule design (Chemistry42)
Generative biologics for novel protein and antibody design
Clinical trial outcome prediction and optimization (inClinico)
Multi-agent LLMs for scientific research and content creation (Science42: DORA)
Foundation models for AI-native drug discovery workflows (Nach01)
Technical Specifications
API Available
SDK Available
MCP Compatible
Open Source
Team Features
SSO/Enterprise
Webhook Support
Has Demo
Deployment:
CLOUD
Compliance & Security
GDPR Compliant
Pros
- +End-to-end AI platform covering the entire drug discovery pipeline
- +Proven track record with multiple preclinical and clinical candidates
- +Strong external validation through collaborations with top global pharma companies
- +Robust security measures including ISO 27001 certification and encrypted data handling
- +Flexibility with client-preferred cloud servers (AWS, Azure) for data residency
Limitations
- -Requires deep scientific and technical expertise for effective utilization
- -No public pricing or self-service options, exclusively for enterprise clients
- -High complexity may involve a significant learning curve for new users
- -Specific integration details beyond major cloud providers are not publicly detailed
- -No explicit free trial or demo available for direct user evaluation
Powered By
Base Models
Reinforcement LearningGenerative Adversarial Networks (GANs)
Uses Models
PandaOmicsChemistry42InClinicoReinforcement Learning
Decision Intelligence
Best For
Accelerating drug discovery for pharmaceutical companies
Identifying novel therapeutic targets for disease treatment
Generating new small molecules and biologics with desired properties
Optimizing clinical trial design and predicting outcomes
Enhancing scientific research with AI-driven insights
Not Ideal For
Individual researchers or small startups with limited budgets
Users seeking a simple, off-the-shelf AI tool for basic tasks
Organizations without a dedicated R&D team or scientific expertise
Companies looking for open-source drug discovery solutions
Users requiring immediate, self-service access without a formal engagement process
Frequently Asked Questions
Your Actions
Dimension Scores
Ease of Use3/10
Output Quality8/10
Value for Money7/10
Customization5/10
Support6/10
Integration6/10
Task Scores
Research Analysis
9
Compliance Tracking
6
Diagnosis Support
3
Clinical Documentation
2
Patient Communication
1
Drug Interaction Check
1
Health Monitoring
1
Appointment Management
1
Trust Score
60/100
Fair
Based on 6 verified signals
Trust Signals
Verified CompanyInsilico Medicine
Notable CustomersEli Lilly, Servier, Qilu Pharmaceutical +5
Funding$1.05 Billion
Team Size201-500
GDPR CompliantYes
Data ResidencyUS, EU, APAC
Switching & Migration
Migration Difficulty
Significant Effort
Data portable as:
API
Email only
Quick Stats